Vortioxetine in treatment of depression with somatic comorbidities in routine practice: sub-group analysis of the RELIEVE study
Improvements in functioning and symptoms were observed over the 24-week period among patients with MDD and comorbid obesity, sleep disorders, cardiovascular disease, chronic pain, or diabetes, receiving vortioxetine treatment in routine practice.
Authors
- Daniel Oudin Åström (ORCID: https://orcid.org/0000-0003-4742-417X)
- Amar Mehta (ORCID: https://orcid.org/0000-0003-0882-973X)
- Gregory W. Mattingly (ORCID: https://orcid.org/0000-0002-0234-6860)
- Elin Heldbo Reines (ORCID: https://orcid.org/0000-0002-1151-9102)
- David S. Baldwin (ORCID: https://orcid.org/0000-0003-3343-0907)
Institutions
- Political Research Associates (US)
- Lundbeck (Denmark) (DK)
- University of Cape Town (ZA)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.jad.2025.120676
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39